Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ovarian squamous cell carcinoma: clinicopathological features, prognosis and immunotherapy outcomes.

Journal of gynecologic oncology - 1 Jul 2025

Zhang Tianyu, Yang Jie, Li Sijian, Shi Xiaohua, Yang Jiaxin

Abstract excerpt

OBJECTIVE: To explore the characteristics and survival outcomes of ovarian squamous cell carcinoma (SCC) and the treatment effectiveness of immune checkpoint inhibitors (ICIs). METHODS: Patients diagnosed with ovarian SCC at Peking Union Medical College Hospital between January 2000 and September 2023 were included. Overall survival (OS) and progression-free survival (PFS) were analyzed using the Kaplan-Meier...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Squamous Cell
Share to Chemotherapy, Adjuvant

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Class I Phosphatidylinositol 3-Kinases

Share to Immune Checkpoint Inhibitors

Share to Ovarian Neoplasms

Share to Prognosis

Share to Progression-Free Survival

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 39791511
DOI: 10.3802/jgo.2025.36.e54
PMCID: PMC12226324

Genes

PIK3CA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ovarian squamous cell carcinoma: clinicopathological features, prognosis and immunotherapy outcomes.PMID 39791511Read ↗

[Clinical and pathological characteristics of ovary mature cystic teratoma squamous cell carcinoma and primary ovarian squamous cell carcinoma].Semantic proximity Read ↗

Establishment and Characterization of Preclinical Model of Primary Ovarian Squamous Cell CarcinomaSemantic proximity Read ↗

Comprehensive characterization of genomic features and clinical outcomes following targeted therapy and secondary cytoreductive surgery in OCCC: a single center experience.Semantic proximity Read ↗

Molecular characterization of ovarian squamous cell carcinoma originating from mature teratomaSemantic proximity Read ↗

The Driver Mutational Landscape of Ovarian Squamous Cell Carcinomas Arising in Mature Cystic Teratoma.Semantic proximity Read ↗

The genomic landscape of low-grade serous ovarian/peritoneal carcinoma and its impact on clinical outcomes.Semantic proximity Read ↗

Ovarian Cancer in the Era of Immune Checkpoint Inhibitors: State of the Art and Future Perspectives.Semantic proximity Read ↗

Squamous cell carcinoma arising from ovarian mature cystic teratoma with concurrent cervical high-risk HPV infection and low-grade squamous intraepithelial lesion: A case reportSemantic proximity Read ↗

Genomic, Trop-2, and Immune Profiles of Carcinomatous and Sarcomatous Components in Ovarian Carcinosarcoma.Semantic proximity Read ↗

Oncogenic pathway landscape of ovarian cancer and correlation with clinical prognosis.Semantic proximity Read ↗

APOBEC3B stratifies ovarian clear cell carcinoma with distinct immunophenotype and prognosis.Semantic proximity Read ↗

Clinicopathological characterization of a real-world multicenter cohort of endometrioid ovarian carcinoma: Analysis of the French national ESME-Unicancer database.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.